Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-nasal Ketorolac vs Oral Diclofenac for Ureteral Stent Pain
NCT06158620Phase 2Recruiting
- Sponsor
- UT Southwestern Medical Center
- Start
- Mar 2025
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ketorolac in postoperative pain (2 arms), sponsored by UT Southwestern Medical Center. Primary endpoints: Change in pain scores as measured by USSQ Pain Survey, Change in pain scores as measured by PROMIS questionnaire and 1 more. Started Mar 2025; status: recruiting.
02
Drugs
ketorolac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06158620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06158620.